RFP TRND 3 11 27 24 Final Clean.pdf
Posted: Dec. 20, 2024
• Type: .pdf
• Size: 0.87MB
Opportunity Assistant
Loading
Overview
Related Opportunity
Related Agency
Profiled People
Summary
This request for proposal (RFP) is issued by the National Institutes of Health (NIH), specifically the NIDA Office of Acquisitions, under RFP number 75N95025R00005.
The solicitation seeks proposals for chemistry, manufacturing, and controls (CMC) and related services necessary for the development of drug products. The objective is to ensure that drug products (DP) are delivered with sufficient quality and quantity to support preclinical and investigational new drug (IND)-enabling studies.
Proposals must be submitted electronically via the NIH Electronic Contract Proposal Submission (ECPS) website by 3:00 PM local time on February 3, 2025.
The contract will be structured as a multiple award indefinite quantity contract, with a minimum reimbursement of $1,000 and a maximum of $49,885,703 for successful performance.
The ordering period spans from September 30, 2025, to July 31, 2031. Offerors must be registered in the System for Award Management (SAM) prior to contract award and are encouraged to submit questions to the contract specialist by December 23, 2024.
The evaluation of proposals will consider technical capabilities, past performance, and cost/price factors as detailed in the solicitation's evaluation criteria. Additionally, all reports generated under this contract must comply with Section 508 of the Rehabilitation Act of 1973 regarding accessibility.
The solicitation seeks proposals for chemistry, manufacturing, and controls (CMC) and related services necessary for the development of drug products. The objective is to ensure that drug products (DP) are delivered with sufficient quality and quantity to support preclinical and investigational new drug (IND)-enabling studies.
Proposals must be submitted electronically via the NIH Electronic Contract Proposal Submission (ECPS) website by 3:00 PM local time on February 3, 2025.
The contract will be structured as a multiple award indefinite quantity contract, with a minimum reimbursement of $1,000 and a maximum of $49,885,703 for successful performance.
The ordering period spans from September 30, 2025, to July 31, 2031. Offerors must be registered in the System for Award Management (SAM) prior to contract award and are encouraged to submit questions to the contract specialist by December 23, 2024.
The evaluation of proposals will consider technical capabilities, past performance, and cost/price factors as detailed in the solicitation's evaluation criteria. Additionally, all reports generated under this contract must comply with Section 508 of the Rehabilitation Act of 1973 regarding accessibility.
Show All